Reduced number and impaired function of circulating γδ T cells in patients with cutaneous primary melanoma

Journal of Investigative Dermatology

Volumn 120, Issue 5, 2003, Pages 829-834

  Argentati, Katy ^a   Re, Francesca ^a   Serresi, Stefano ^a   Tucci, Maria G ^a   Bartozzi, Beatrice ^a   Bernardini, Giovanni ^a   Provinciali, Mauro ^a  

^a INRCA   (Italy)

Author keywords

Fluorescence activated cell sorter; Human; Melanoma; Tumor immunity; T cells

Indexed keywords

TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ANTIGEN PRESENTATION; ARTICLE; CELLULAR IMMUNITY; CLINICAL ARTICLE; CYTOKINE RELEASE; CYTOTOXICITY; ENZYME INDUCTION; FEMALE; FLUORESCENCE ACTIVATED CELL SORTING; HUMAN; HUMAN CELL; IMMUNE RESPONSE; KILLER CELL; MAJOR HISTOCOMPATIBILITY COMPLEX RESTRICTION; MALE; MELANOMA; PRIORITY JOURNAL; SKIN TUMOR; T LYMPHOCYTE ACTIVATION; TUMOR GROWTH; TUMOR IMMUNITY;

EID: 0038297514     PISSN: 0022202X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1747.2003.12141.x     Document Type: Article

References (43)

1. Argentati K, Re F, Donnini A, et al: Numerical and functional alterations of circulating γδ T lymphocytes in aged people and centenarians. J Leukocyte Biol 72:65-71, 2002
2. Bachelez H, Flageul B, Deos L, Boumsell L, Bensussan A: TCR gamma delta bearing T lymphocytes infiltrating human primary cutaneous melanomas. J Invest Dermatol 98:369-374, 1992
3. Balch CM, Buzaid AC, Atkins MB, et al: A new American Joint Committee on Cancer staging system for cutaneous melanoma. Cancer 88:1484-1491, 2000
4. Bialasiewicz AA, Ma JX, Richard G: Alpha/beta- and gamma/delta TCR(+) lymphocyte infiltration in necrotising choroidal melanomas. Br J Ophthalmol 83:1069-1073, 1999
5. Brenner MB, McLean J, Scheft H, et al: Two forms of the T-cell receptor gamma protein found on peripheral blood cytotoxic T lymphocytes. Nature 325:689-694, 1987
6. Bryant J, Day R, Whiteside T, Hebcrman RB: Calculation of lytic units for the expression of cell-mediated cytotoxicity. J Immunol Methods 146:91-103, 1992
7. Bukowski JF, Morita CT, Tanaka Y, Bloom BR, Brenner MB, Band H: Vγ2Vδ2 TCR-dependent recognition of non-peptide antigens and Daudi cells analyzed by TCR gene transfer. J Immunol 154:998-1006, 1995
8. Burk MR, De Mori L, Libero G: Human Vδ9-Vδ2 cells are stimulated in a cross-reactive fashion by a variety of phosphorylated metabolites. Eur J Immunol 25:2052-2058, 1995
9. + T cells and IL-2. Clin Immunol Immunopathol 80:38-43, 1996a
10. + T cells in the γδ proliferative response to Daudi Burkitt's lymphoma. Cell Immunol 174:19-23, 1996b
11. + αβ T cells. J Leukoc Biol 63:707-712, 1998
12. Costant P, Davodeau F, Peyrat MA, Pouquet Y, Puzo G, Bonneville M, Fournier JJ: Stimulation of γδ T cells by nonpeptidic mycobacterial ligands. Science 264:267-270, 1994
13. Das H, Groh V, Kuijl C. Sugita M, Morita CT, Spies T, Bukowski JF: MICA engagement by human Vγ2Vδ2 T cells enhances their antigen-dependent effector function. Immunity 15:83-93, 2001
14. Dudley ME, Wunderlich J, Nishimura MI, et al: Adoptive transfer of cloned melanoma-reactive T lymphocytes for the treatment of patients with metastatic melanoma. J Immunother 24:363-373, 2001
15. Fearon DT, Locksley RM: The instructive role of innate immunity in the acquired immune response. Science 272:50-54, 1996
16. Ferrick DA, Schrenzel MD, Mulvania T, Hsieh B, Ferlin WG, Lepper H: Differential production of interferon-γ and interleukin-4 in response to Th- and Th-stimulating pathogens by γδ T cells in vivo. Nature 373:255-257, 1995
17. Fisch P, Malkovsky M, Kovats S, et al: Recognition by human Vδ9/Vδ2 T cells of a GroEL homolog on Daudi Burkitt's lymphoma cells. Science 250:1269-1273, 1999
18. Fujimiya Y, Suzuki Y, Katakura R, Miyagi T, Yamaguchi T, Yoshimoto T, Elbina T: In vitro interleukin 12 activation of peripheral blood CD3+CD56+ and CD3+CD56- gammadelta T cells from glioblastoma patients. Clin Cancer Res 3:633-643, 1997
19. Girardi M, Oppenheim DE, Steele CR, et al: Regulation of cutaneous malignancy by γδ T cells. Science 294:607-609, 2001
20. Groh V, Porcelli S, Fabbi M, et al: Human lymphocytes bearing T cell receptor γ/δ are phenotypically diverse and evenly distributed throughout the lymphoid system. J Exp Med 169:1277-1294, 1989
21. Groh V, Rhinehart R, Secrist H, Bauer S, Grabstein KH, Spies T: Broad tumor-associated expression and recognition by tumor-derived γδ T cells of MICAA and MICB. Proc Natl Acad Sci USA 96:6879-6884, 1999
22. Kabelitz D, Wesch D, Hinz T: γδ T cells, their T cell receptor usage and role in human diseases. Springer Semin Immunopathol 21:55-75, 1999
23. Kabelitz D, Glatzel A, Wesch D: Antigen recognition by human γδ T lymphocytes. Int Arch Allergy Immunol 122:1-7, 2000
24. Kammula US, Lee KU, Riker AI, Wang E, Ohnmacht GA, Rosenberg SA, Marincola FM: Functional analysis of antigen-specific T lymphocytes by serial measurement of gene expression in peripheral blood mononuclear cells and tumor specimens. J Immunol 163:6867-6875, 1999
25. Kjeldsen-Kragh J, Quayle AJ, Skalhegg BS, Sioud M, Forre O: Selective activation of resting gamma delta T lymphocytes by interleukin-2. Eur J Immunol 23:2092-2099, 1993
26. Kunzmann V, Bauer E, Feurle J, Weissinger F, Tony HP, Wilhelm M: Stimulation of γδ T cells by aminobisphosphonates and induction of antiplasma cell activity in multiple myeloma. Blood 96:384-392-99, 2000
27. Lahn M, Kalataradi H, Mittelstadt P, et al: Early preferential stimulation of γδ T cells by TNF-α. J Immunol 160:5221-5230, 1998
28. Lee KH, Wang E, Nielsen MB, et al: Increased vaccine-specific T cell frequency after peptide-based vaccination correlates with increased susceptibility to in vitro stimulation but does not lead to tumor regression. J Immunol 163:6292-6300, 1999
29. Mak TW, Ferrick DA: The γδ T-cell bridge: Linking innate and acquired immunity. Nature Med 4:764-765, 1998
30. Medzhitov R, Janeway CA Jr: Innate immunity: Impact on the adaptive immune response. Curr Opin Immunol 9:4-9, 1997
31. Nanno M, Seki H, Mathioudakis G, et al: Gamma/delta T cell antigen receptors expressed on tumor-infiltrating lymphocytes from patients with solid tumors. Eur J Immunol 22:679-687, 1992
32. + T cells. J Immunol 165:2287-2296, 2000
33. Platz A, Hansson J, Mansson-Brahme E, et al: Screening of germline mutations in the CDKH2A and CDKNZB genes in Swedish families with hereditary cutaneous melanoma. J Nat'l Cancer Inst 89:676-678, 1997
34. Poccia F, Cipriani B, Vendetti S, et al: CD94/NKG2 inhibitory receptor complex modulates both anti-viral and anti-tumoral responses of polyclonal phosphoantigen-reactive Vδ9Vδ2 T lymphocytes. J Immunol 159:6009-6017, 1997
35. Poccia F, Gougeon ML, Bonneville M: Innate T cell immunity to nonpeptidic antigens. Immunol Today 19:253-256, 1998
36. 51CR release assay. J Immunol Methods 155:19-24, 1992
37. Strohal R, Marberger K, Pehamberger H, Stingl G: Immunohistological analysis of anti-melanoma host responses. Arch Dermatol Res 287:28-35, 1994
38. Tanaka I, Morita CT, Tanaka Y, Nieves E, Brenner MB, Bloom BR: Natural and synthetic non-peptide antigens recognized by human γδ T cells. Nature 375:155-158, 1995
39. Thor Straten P, Becker JC, Guldberg P, Zeuthen J: In situ T cells in melanoma. Cancer Immunol Immunother 48:386-395, 1999
40. Ueta C, Kawasumi H, Fujiwara H, et al: Interleukin-12 activates human gamma delta T cells, synergistic effect of tumor necrosis factor-alpha. Eur J Immunol 26:3066-3073, 1996
41. Vila LM, Haftel HM, Park H-S, Lin M-S, Romzek NC, Hanash SM, Holoshitz J: Expansion of mycobacterium-reactive γδ T cells by a subset of memory helper T cells. Infect Immun 63:1211-1216, 1995
42. Wu J, Groh V, Spies T: T cell antigen receptor engagement and specificity in the recognition of stress-inducible MHC class I-related chains by human epithelial γδ T cells. J Immunol 169:1236-1240, 2002
43. Zheng BJ, Chan K W, Im S, et al: Anti-tumor effects of human peripheral gammadelta T cells in a mouse tumor model. Int J Cancer 92:421-425, 2001